MOBX.NASDAQMobix Labs, INC

4/A: Mobix Labs Director Corrects Form 4 Filing, Clarifies Option Acquisition

Sentiment:

SEC Form 4/A


Kurt Busch, a director at Mobix Labs, Inc., amended a previous Form 4 filing to accurately reflect the acquisition of options rather than shares of Class A Common Stock.

Summary

  • Kurt Busch, a director of Mobix Labs, Inc., filed an amended Form 4 to correct a previous filing from December 26, 2023.
  • The amendment clarifies that the acquisition on December 21, 2023, involved options, not shares of Class A Common Stock.
  • Busch acquired 20,000 options with an exercise price of $4.18 and 133,416 options with an exercise price of $6.84.
  • These options were received in connection with the business combination between Chavant Capital Acquisition Corp., CLAY Merger Sub II, Inc., and Mobix Labs, Inc., which closed on December 21, 2023.
  • The options are fully vested and exercisable.
  • The director does not directly hold any shares of Class A Common Stock.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing correcting a previous error. It doesn't contain any particularly positive or negative news, but the correction itself is a positive sign of transparency.

Positives

  • The correction provides clarity on the director's holdings, specifically regarding options versus shares.
  • The options are fully vested and exercisable, indicating potential future benefit for the director.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, ensuring fair markets.

Stakeholder Impact

  • Shareholders benefit from accurate reporting of insider transactions.

Key Dates

DateDescription
November 15, 2022Date of the Business Combination Agreement between Chavant Capital Acquisition Corp., CLAY Merger Sub II, Inc. and Mobix Labs, Inc.
December 21, 2023Closing Date of the Business Combination and date of options acquisition.
December 26, 2023Date of original Form 4 filing that incorrectly reported the acquisition of shares.
August 10, 2030Expiration date for 20,000 options with an exercise price of $4.18.
April 04, 2032Expiration date for 133,416 options with an exercise price of $6.84.
March 10, 2025Date of the amended Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.